Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Physiopathological Roles of p2x Receptors in the Central Nervous System.
Teva to present positive data for glatiramer acetate 40 mg/1 ml given three times weekly for relapsing-remitting MS
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
The history of the oxazaphosphorine cytostatics.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
European Congress of Immunology 2012
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients.
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting: Alemtuzumab (BLA 103948\5139) Background Package
Stress Management and Multiple Sclerosis: A Randomized Controlled Trial.
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.
Guillain-Barré syndrome: clinical profile and management.
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset.

Pages